XBiotech Inc.
XBIT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $81,097 | $90,549 | $98,780 | $120,321 |
| - Cash | $147,367 | $152,938 | $155,897 | $172,677 |
| + Debt | $0 | $0 | $0 | $10,250 |
| Enterprise Value | -$66,270 | -$62,389 | -$57,117 | -$42,106 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$427 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5,479 | -$1,289 | -$10,325 | -$9,906 |
| % Margin | – | – | – | – |
| Net Income | -$6,008 | -$1,756 | -$10,884 | -$10,508 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.2 | -0.058 | -0.36 | -0.34 |
| % Growth | -247.2% | 84% | -5.9% | – |
| Operating Cash Flow | -$4,259 | -$5,989 | -$6,720 | -$6,540 |
| Capital Expenditures | -$110 | -$51 | -$94 | -$84 |
| Free Cash Flow | -$4,369 | -$6,040 | -$6,814 | -$6,624 |